STERIS (2TG) Stock Overview
Provides infection prevention products and services in the United States, Ireland, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
2TG Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
STERIS plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$178.60 |
| 52 Week High | US$232.00 |
| 52 Week Low | US$162.90 |
| Beta | 0.92 |
| 1 Month Change | -1.33% |
| 3 Month Change | -5.50% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | 1.25% |
| Change since IPO | 561.48% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2TG | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 8.4% | -1.2% | -2.4% |
| 1Y | n/a | -29.2% | -0.6% |
Return vs Industry: Insufficient data to determine how 2TG performed against the German Medical Equipment industry.
Return vs Market: Insufficient data to determine how 2TG performed against the German Market.
Price Volatility
| 2TG volatility | |
|---|---|
| 2TG Average Weekly Movement | 7.2% |
| Medical Equipment Industry Average Movement | 5.8% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in DE Market | 13.3% |
| 10% least volatile stocks in DE Market | 2.8% |
Stable Share Price: 2TG has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 2TG's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1985 | 17,937 | Dan Carestio | www.steris.com |
STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services.
STERIS plc Fundamentals Summary
| 2TG fundamental statistics | |
|---|---|
| Market cap | €18.20b |
| Earnings (TTM) | €685.06m |
| Revenue (TTM) | €5.20b |
Is 2TG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2TG income statement (TTM) | |
|---|---|
| Revenue | US$5.94b |
| Cost of Revenue | US$3.31b |
| Gross Profit | US$2.63b |
| Other Expenses | US$1.84b |
| Earnings | US$782.30m |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 8.03 |
| Gross Margin | 44.24% |
| Net Profit Margin | 13.18% |
| Debt/Equity Ratio | 26.8% |
How did 2TG perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/30 03:38 |
| End of Day Share Price | 2026/06/30 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2026/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
STERIS plc is covered by 17 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Polark | Baird |
| Erin Wilson Wright | BofA Global Research |
| David Turkaly | Citizens JMP Securities, LLC |